Search Within

Laura Hong Tang

  1. "MSK Grad Students"
Formats
  1. Journal Article (12)
  2. Meeting Abstract (8)
Groups
  1. Department of Pathology and Laboratory Medicine (20)
  2. GSK Faculty (20)
  3. Human Oncology and Pathogenesis Program (20)
  4. MSK Grad Students (20)
  5. Department of Medicine (19)
  6. Epidemiology and Biostatistics (19)

More Groups

People
  1. Nikolaus Schultz (17)
  2. Walid Chatila (17)
  3. Yelena Janjigian (15)
  4. Geoffrey Ku (11)
  5. David Ilson (10)
  6. David Kelsen (9)

More People

Years
  1. 2024 (2)
  2. 2023 (4)
  3. 2022 (3)
  4. 2021 (1)
  5. 2020 (4)
  6. 2019 (2)

More Years

Publications
  1. Journal of Clinical Oncology (8)
  2. Clinical Cancer Research (3)
  3. Nature (2)
  4. American Surgeon (1)
  5. Annals of Surgery (1)
  6. Cancer Discovery (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (9)
  2. American Association for Cancer Research (4)
  3. Nature Publishing Group (3)
  4. Elsevier Inc. (1)
  5. Lippincott Williams & Wilkins (1)
  6. Oxford University Press (1)

More Publishers

Results (20)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Systemic chemotherapy for metastatic colitis-associated cancer has a worse outcome than sporadic colorectal cancer: Matched case cohort analysis
    Journal Article

    Yaeger, R.; Paroder, V.; Bates, D. D. B.; Capanu, M.; Chou, J.; Tang, L.; Chatila, W.; Schultz, N.; Hersch, J.; Kelsen, D.
    Clinical Colorectal Cancer (2020)

    Fulltext@MSK | Save
  • PD-L1 positive esophagogastric (EG) cancer is associated with distinct bacteria
    Meeting Abstract

    Maron, S. B.; Vanderbilt, C.; Sabwa, S.; Bowman, A.; Chatila, W. K.; Tang, L. H.; Strong, V. E.; Molena, D.; Jones, D. R.; Coit, D. G.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Genomic alterations in colitis-associated cancers in comparison to those found in sporadic colorectal cancer and present in precancerous dysplasia
    Meeting Abstract

    Chatila, W. K.; Walch, H. S.; Benhamida, J.; Hechtman, J. F.; Barriga, F. M.; Kundra, R.; Ismalgeci, D.; Miller, V. A.; Ganesh, K.; Faleck, D.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Genomic correlates of extreme pathologic response following neoadjuvant chemotherapy in locally advanced gastric cancer to reveal distinct vulnerabilities
    Meeting Abstract

    Datta, J.; Walch, H. S.; Russo, A.; Chatila, W. K.; Vos, E.; Bhanot, U.; Janjigian, Y. Y.; Schultz, N.; Tang, L. H.; Strong, V. E.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Clinical and molecular predictors of response to immune checkpoint inhibitors in patients with advanced esophagogastric cancer
    Journal Article

    Greally, M.; Chou, J. F.; Chatila, W. K.; Margolis, M.; Capanu, M.; Hechtman, J. F.; Tuvy, Y.; Kundra, R.; Daian, F.; Ladanyi, M.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Efficacy of combined VEGFR1-3, PDGFα/β, and FGFR1-3 blockade using nintedanib for esophagogastric cancer
    Journal Article

    Won, E.; Basunia, A.; Chatila, W. K.; Hechtman, J. F.; Chou, J. F.; Ku, G. Y.; Chalasani, S. B.; Boyar, M. S.; Goldberg, Z.; Desai, A. M.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Tumor mutation burden (TMB) and immune- related adverse events (irAEs) compared to antibiotic (abx) use to predict for response to immune checkpoint inhibitors in esophagogastric cancer (EGC)
    Meeting Abstract

    Greally, M.; Chatila, W. K.; Margolis, M.; Hechtman, J. F.; Tuvy, Y.; Kundra, R.; Ladanyi, M.; Kelsen, D. P.; Ilson, D. H.; Berger, M. F.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Genetic predictors of response to systemic therapy in esophagogastric cancer
    Journal Article

    Janjigian, Y. Y.; Sanchez-Vega, F.; Jonsson, P.; Chatila, W. K.; Hechtman, J. F.; Ku, G. Y.; Riches, J. C.; Tuvy, Y.; Kundra, R.; Bouvier, N.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • Correlation of benefit from immune checkpoint inhibitors with next gen sequencing (NGS) profiles in esophagogastric cancer (EGC) patients
    Meeting Abstract

    Ku, G. Y.; Sanchez-Vega, F.; Chatila, W.; Margolis, M.; Fein, C.; Ilson, D. H.; Hechtman, J. F.; Tuvy, Y.; Bouvier, N.; Kundra, R.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Comprehensive molecular characterization of gastric adenocarcinoma
    Journal Article

    The Cancer Genome Atlas Research Network
    Nature (2014)

    Fulltext@MSK | Save